At Biogen, our mission is clear: we are pioneers in neuroscience.Since our founding in 1978 as one of the world’s first global biotechnology companies by Charles Weissmann, Heinz Schaller, Kenneth Murray and Nobel Prize winners Walter Gilbert and Phillip Sharp, Biogen has led innovative scientific research with the goal over the last decade to defeat devastating neurological diseases. Millions of people around the world are affected by multiple sclerosis, Alzheimer’s disease, Parkinson’s disease and amyotrophic lateral sclerosis (ALS). Many people also suffer from less common diseases such as spinal muscular atrophy (SMA) and progressive supranuclear palsy (PSP). Biogen has some of the world’s best neurologists and neuroscientists. We engage with physicians and scientific leaders around the world with the aim to further medical research. Our focus on neuroscience, our deep scientific expertise and our courage to take risks make us leaders in the research and development of medicines to transform neuroscience to benefit society. Our technology and engineering capabilities create novel ways to seamlessly transition products from development to manufacturing with the intent of bringing our high-quality medicines to market faster. We respect the contributions of health care providers caring for people living with neurological diseases. We honor the important role of caregivers, families and friends who care about them. Biogen is committed to working with advocacy and patient organizations as they serve the communities they represent. Recognizing the challenges facing healthcare systems today, we collaborate with regulatory authorities and customers such as health care providers and payers, so that those in need can access our medicines.
Biogen currently has 0 opportunities.
Select the following options: